The European Society for Organ Transplantation (ESOT) has signed an agreement to develop a series of web-based registries on organ transplantation with Dendrite Clinical Systems Ltd. The Council of the European Society for Organ Transplantation took the decision to partner with Dendrite after a rigorous, competitive tender process.

The Sixth IFSO Global Registry Report (2021) has been published by Dendrite Clinical Systems, under the auspices of the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO). The publication reports data from 50 countries on over 507,290 operations including baseline obesity-related disease, operation types, operative outcomes and disease status after bariatric surgery.

Dendrite Clinical Systems and Professor Khalid Ali Al-Rubeaan, Director of the Research and Scientific Center at the Sultan Bin Abdulaziz Humanitarian City hospital, Saudi Arabia, have established the Saudi National Bariatric Surgery Registry (SNBR) in the country. The purpose of the Registry is to collect information on bariatric procedures in the country so researchers can use the data to improve outcomes.

Dendrite Clinical Systems and the British Society for Allergy & Clinical Immunology () have published the ‘First BSACI Registry for Immunotherapy Report (2020)’. The report is believed to be the first national registry report that has collected, analysed and documented the outcomes for patients receiving allergen immunotherapy to aeroallergens and venom, as well as omalizumab for chronic urticaria, anywhere in the world.

An international team of scientists are investigating a possible curious bi-directional relationship between COVID-19 and diabetes. The researchers, who are part of the CoviDiab project, have hypothesised that the SARS-CoV-2 infection maybe be triggering the onset of diabetes, and they have established a global registry to track occurrence of events and are calling for doctors around the world to contribute reports of cases of new-onset diabetes associated with COVID-19.

For nearly a decade, Dendrite Clinical Systems and Device Access UK have been combining their expertise in clinical registries and market access and reimbursement, respectively, to expedite the regulatory processes for MedTech companies to get their technologies to patients.  Working in conjunction with small, medium and large multinational companies, the partnership has enabled clients to record, collect and analyse real-world evidence and present data that adheres to the necessary regulatory guidance and requirements.